XSHE
300288
Market cap477mUSD
Oct 09, Last price
9.78CNY
1D
3.49%
1Q
7.59%
IPO
-25.97%
Name
Guiyang Longmaster Information & Technology Co Ltd
Chart & performance
P/E
353.80
P/S
11.09
EPS
0.03
Div yield, %
0.16%
Shrs. gr., 5y
-1.46%
Rev. gr., 5y
-5.99%
Revenues
298m
-21.36%
Net income
9m
P
CFO
21m
-55.62%
Dividend
Jul 14, 20260.01 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Longmaster Information & Technology Co., Ltd. is a Chinese enterprise dedicated to online healthcare services. The company delivers a broad spectrum of medical solutions, encompassing remote consultations (telemedicine), access to health information, virtual doctor appointments via video, the operation of traditional physical hospitals, development of intelligent medical devices, and an e-commerce platform for healthcare products. This firm was established in 1998 and has its main office located in Guiyang, China.
Key people
Wei Wang
Chairman of the Board, General Manager · since 2024
Dan Tian
Deputy General Manager · since 2019
Chun Wang
Chief Financial Officer, Deputy General Manager, Secretary of the Board, Director · since 2019
Yueyue Xiao
Director · since 2024
Wende Chen
Independent Director · since 2023
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||